MASP INHIBITORY COMPOUNDS AND USES THEREOF

The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERSTEEGEN, Adrian, NEUBAUER, Thomas, ZUBOV, Dmitry, GLATZ, Marie, DREHER, Jan, BAUMANN, Lars, POETHKO, Thorsten, BIERER, Donald, TERJUNG, Carsten, FLAMME, Ingo, HOLTON, Simon, QIU, Yibo, XIONG, Jiancheng, JUHL, Cathleen
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TERSTEEGEN, Adrian
NEUBAUER, Thomas
ZUBOV, Dmitry
GLATZ, Marie
DREHER, Jan
BAUMANN, Lars
POETHKO, Thorsten
BIERER, Donald
TERJUNG, Carsten
FLAMME, Ingo
HOLTON, Simon
QIU, Yibo
XIONG, Jiancheng
JUHL, Cathleen
description The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG11202111587VA</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG11202111587VA</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG11202111587VA3</originalsourceid><addsrcrecordid>eNrjZNDydQwOUPD08_B08gzxD4pUcPb3DfAP9XMJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxwe6GhkYGRoaGhqYW5mGOxkQqAwA6oSY5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MASP INHIBITORY COMPOUNDS AND USES THEREOF</title><source>esp@cenet</source><creator>TERSTEEGEN, Adrian ; NEUBAUER, Thomas ; ZUBOV, Dmitry ; GLATZ, Marie ; DREHER, Jan ; BAUMANN, Lars ; POETHKO, Thorsten ; BIERER, Donald ; TERJUNG, Carsten ; FLAMME, Ingo ; HOLTON, Simon ; QIU, Yibo ; XIONG, Jiancheng ; JUHL, Cathleen</creator><creatorcontrib>TERSTEEGEN, Adrian ; NEUBAUER, Thomas ; ZUBOV, Dmitry ; GLATZ, Marie ; DREHER, Jan ; BAUMANN, Lars ; POETHKO, Thorsten ; BIERER, Donald ; TERJUNG, Carsten ; FLAMME, Ingo ; HOLTON, Simon ; QIU, Yibo ; XIONG, Jiancheng ; JUHL, Cathleen</creatorcontrib><description>The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211129&amp;DB=EPODOC&amp;CC=SG&amp;NR=11202111587VA$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211129&amp;DB=EPODOC&amp;CC=SG&amp;NR=11202111587VA$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERSTEEGEN, Adrian</creatorcontrib><creatorcontrib>NEUBAUER, Thomas</creatorcontrib><creatorcontrib>ZUBOV, Dmitry</creatorcontrib><creatorcontrib>GLATZ, Marie</creatorcontrib><creatorcontrib>DREHER, Jan</creatorcontrib><creatorcontrib>BAUMANN, Lars</creatorcontrib><creatorcontrib>POETHKO, Thorsten</creatorcontrib><creatorcontrib>BIERER, Donald</creatorcontrib><creatorcontrib>TERJUNG, Carsten</creatorcontrib><creatorcontrib>FLAMME, Ingo</creatorcontrib><creatorcontrib>HOLTON, Simon</creatorcontrib><creatorcontrib>QIU, Yibo</creatorcontrib><creatorcontrib>XIONG, Jiancheng</creatorcontrib><creatorcontrib>JUHL, Cathleen</creatorcontrib><title>MASP INHIBITORY COMPOUNDS AND USES THEREOF</title><description>The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDydQwOUPD08_B08gzxD4pUcPb3DfAP9XMJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxwe6GhkYGRoaGhqYW5mGOxkQqAwA6oSY5</recordid><startdate>20211129</startdate><enddate>20211129</enddate><creator>TERSTEEGEN, Adrian</creator><creator>NEUBAUER, Thomas</creator><creator>ZUBOV, Dmitry</creator><creator>GLATZ, Marie</creator><creator>DREHER, Jan</creator><creator>BAUMANN, Lars</creator><creator>POETHKO, Thorsten</creator><creator>BIERER, Donald</creator><creator>TERJUNG, Carsten</creator><creator>FLAMME, Ingo</creator><creator>HOLTON, Simon</creator><creator>QIU, Yibo</creator><creator>XIONG, Jiancheng</creator><creator>JUHL, Cathleen</creator><scope>EVB</scope></search><sort><creationdate>20211129</creationdate><title>MASP INHIBITORY COMPOUNDS AND USES THEREOF</title><author>TERSTEEGEN, Adrian ; NEUBAUER, Thomas ; ZUBOV, Dmitry ; GLATZ, Marie ; DREHER, Jan ; BAUMANN, Lars ; POETHKO, Thorsten ; BIERER, Donald ; TERJUNG, Carsten ; FLAMME, Ingo ; HOLTON, Simon ; QIU, Yibo ; XIONG, Jiancheng ; JUHL, Cathleen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG11202111587VA3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>TERSTEEGEN, Adrian</creatorcontrib><creatorcontrib>NEUBAUER, Thomas</creatorcontrib><creatorcontrib>ZUBOV, Dmitry</creatorcontrib><creatorcontrib>GLATZ, Marie</creatorcontrib><creatorcontrib>DREHER, Jan</creatorcontrib><creatorcontrib>BAUMANN, Lars</creatorcontrib><creatorcontrib>POETHKO, Thorsten</creatorcontrib><creatorcontrib>BIERER, Donald</creatorcontrib><creatorcontrib>TERJUNG, Carsten</creatorcontrib><creatorcontrib>FLAMME, Ingo</creatorcontrib><creatorcontrib>HOLTON, Simon</creatorcontrib><creatorcontrib>QIU, Yibo</creatorcontrib><creatorcontrib>XIONG, Jiancheng</creatorcontrib><creatorcontrib>JUHL, Cathleen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERSTEEGEN, Adrian</au><au>NEUBAUER, Thomas</au><au>ZUBOV, Dmitry</au><au>GLATZ, Marie</au><au>DREHER, Jan</au><au>BAUMANN, Lars</au><au>POETHKO, Thorsten</au><au>BIERER, Donald</au><au>TERJUNG, Carsten</au><au>FLAMME, Ingo</au><au>HOLTON, Simon</au><au>QIU, Yibo</au><au>XIONG, Jiancheng</au><au>JUHL, Cathleen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MASP INHIBITORY COMPOUNDS AND USES THEREOF</title><date>2021-11-29</date><risdate>2021</risdate><abstract>The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_SG11202111587VA
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title MASP INHIBITORY COMPOUNDS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A52%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERSTEEGEN,%20Adrian&rft.date=2021-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG11202111587VA%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true